A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

Lignende værker

• Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma
  af: Tan-Huy Chu, et al.
  Udgivet: (2022-06-01)
• Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model
  af: Thangaraj, Jaya Lakshmi, et al.
  Udgivet: (2021)
• Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
  af: Vo, Manh-Cuong, et al.
  Udgivet: (2017)
• Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model
  af: Vo, Manh-Cuong, et al.
  Udgivet: (2018)
• Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma
  af: Vo, Manh-Cuong, et al.
  Udgivet: (2018)